Zoetis announces US label update for Librela® (bedinvetmab injection), a treatment to control canine osteoarthritis (OA) pain
Zoetis plans to immediately implement updated label based on U.S. post-approval experience with Librela Company remains confident in the safety and effectiveness of Librela and reaffirms its commitment to supporting veterinarians and pet owners in helping dogs with OA live with less